Mereo Biopharma Group Plc (MREO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Mereo Biopharma Group Plc (MREO) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Mereo Biopharma Group Plc

· MREO

Dashboard

Financials

Ratios

Valuation

Statistics

59.57 M

+7.72%

General

Market Cap: $59.57M
Enterprise Value: $35.08M
Shares Outstanding: 798,090,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -80.88%
ROE: -74.76%
ROIC: -111.41%
Current Ratio: 5.88
Debt-to-Equity: 0.04
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 2.24
EV/EBITDA: -1.06

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 255.00%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $33.28M
Operating Income: -$34.17M
Net Profit: -$28.08M

Balance Sheet

Cash and Equivalents: $30.12M
Working Capital: $27.72M
Total Assets: $34.71M
Net Debt: -$29.09M
Total Liabilities: $6.06M
Total Equity: $28.65M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$25.35M
Cash Flow from Investing: -$1.52K
Cash Flow from Financing: $100.73K
Free Cash Flow: -$25.35M
Capital Expenditures: $1.52K